You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 6, June 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Megaloblastic Anemia During Anticonvulsant Drug Therapy

A Case Report and Review of the Literature

JOHN L. PENNY, MD

Arch Intern Med. 1963;111(6):744-749.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Diphenylhydantoin (Dilantin) has been used extensively as anticonvulsant therapy since its introduction in 1938, as has phenobarbital since 1912. It was not until 1952 that Mannheimer et al.1 described leukopenia and megaloblastic anemia in an epileptic patient being treated with diphenylhydantoin. After the administration of cyanocobalamin (vitamin B12) the blood gradually returned to normal. Badenoch2 in 1954 was the first to suggest a causal relationship between megaloblastic anemia and anticonvulsant medication in two case reports. Diphenylhydantoin, primidone (Mysoline), and barbiturates either singly or in combination have been shown capable of inducing megaloblastic anemia.

The purpose of this report is to describe a case of megaloblastic anemia associated with diphenylhydantoin and phenobarbital therapy and to review the literature on this subject.

Report of Case

A 50-year-old white woman entered St. Vincent's Hospital for the first time on Dec. 7, 1961, because of increasing weakness and shortness of breath . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Department of Medicine, St. Vincent's Hospital.; Former Medical Resident, St. Vincent's Hospital; presently Captain, U.S. Army.


Footnotes

Received for publication Oct. 10, 1962; accepted Nov. 28.

Dr. William J. Grace, Director of Medicine, and Dr. Zackery Komnios, Director of Hematology, both of St. Vincent's, New York; Col William H. Crosby, Jr, Director of Hematology, Walter Reed General Hospital, Washington, DC, and Dr. Theodore B. Van Itallie, Director of Medicine, St. Luke's Hospital, New York, gave assistance in preparing this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.